+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 1gaf | ||||||
---|---|---|---|---|---|---|---|
タイトル | 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID | ||||||
要素 | (CHIMERIC 48G7 FAB) x 2 | ||||||
キーワード | CATALYTIC ANTIBODY / ESTER HYDROLYSIS / ESTEROLYTIC / FAB | ||||||
機能・相同性 | 機能・相同性情報 IgD immunoglobulin complex / IgA immunoglobulin complex / IgM immunoglobulin complex / IgE immunoglobulin complex / Fc-gamma receptor I complex binding / CD22 mediated BCR regulation / complement-dependent cytotoxicity / IgG immunoglobulin complex / antibody-dependent cellular cytotoxicity / Fc epsilon receptor (FCERI) signaling ...IgD immunoglobulin complex / IgA immunoglobulin complex / IgM immunoglobulin complex / IgE immunoglobulin complex / Fc-gamma receptor I complex binding / CD22 mediated BCR regulation / complement-dependent cytotoxicity / IgG immunoglobulin complex / antibody-dependent cellular cytotoxicity / Fc epsilon receptor (FCERI) signaling / Classical antibody-mediated complement activation / Initial triggering of complement / immunoglobulin complex, circulating / immunoglobulin receptor binding / FCGR activation / immunoglobulin mediated immune response / Role of phospholipids in phagocytosis / Role of LAT2/NTAL/LAB on calcium mobilization / Scavenging of heme from plasma / complement activation, classical pathway / FCERI mediated Ca+2 mobilization / FCGR3A-mediated IL10 synthesis / antigen binding / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / Regulation of Complement cascade / Cell surface interactions at the vascular wall / FCGR3A-mediated phagocytosis / FCERI mediated MAPK activation / B cell receptor signaling pathway / Regulation of actin dynamics for phagocytic cup formation / FCERI mediated NF-kB activation / Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell / antibacterial humoral response / Interleukin-4 and Interleukin-13 signaling / adaptive immune response / blood microparticle / Potential therapeutics for SARS / immune response / extracellular space / extracellular exosome / extracellular region / plasma membrane 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 解像度: 1.95 Å | ||||||
データ登録者 | Wedemayer, G.J. / Patten, P.A. / Stevens, R.C. / Schultz, P.G. | ||||||
引用 | ジャーナル: Science / 年: 1996 タイトル: The immunological evolution of catalysis. 著者: Patten, P.A. / Gray, N.S. / Yang, P.L. / Marks, C.B. / Wedemayer, G.J. / Boniface, J.J. / Stevens, R.C. / Schultz, P.G. #1: ジャーナル: Proc.Natl.Acad.Sci.USA / 年: 1993 タイトル: A Genetic Approach to the Generation of Antibodies with Enhanced Catalytic Activities 著者: Lesley, S.A. / Patten, P.A. / Schultz, P.G. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 1gaf.cif.gz | 115.3 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb1gaf.ent.gz | 93.8 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 1gaf.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 1gaf_validation.pdf.gz | 723.6 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 1gaf_full_validation.pdf.gz | 729.7 KB | 表示 | |
XML形式データ | 1gaf_validation.xml.gz | 18.7 KB | 表示 | |
CIF形式データ | 1gaf_validation.cif.gz | 26.6 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ga/1gaf ftp://data.pdbj.org/pub/pdb/validation_reports/ga/1gaf | HTTPS FTP |
-関連構造データ
類似構造データ |
---|
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-要素
#1: 抗体 | 分子量: 23485.045 Da / 分子数: 1 断片: VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 由来タイプ: 組換発現 詳細: BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY ...詳細: BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN 由来: (組換発現) Homo sapiens (ヒト) 解説: EACH CHAIN IS A FUSION POLYPEPTIDE WHICH IS PART HUMAN AND PART MOUSE 細胞株: 48G7 / 断片: CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS / プラスミド: PSAL143 / 発現宿主: BL21 / 参照: GenBank: 4768677, UniProt: P01834*PLUS |
---|---|
#2: 抗体 | 分子量: 23209.020 Da / 分子数: 1 断片: VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 由来タイプ: 組換発現 詳細: BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY ...詳細: BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN 由来: (組換発現) Homo sapiens (ヒト) 解説: EACH CHAIN IS A FUSION POLYPEPTIDE WHICH IS PART HUMAN AND PART MOUSE 細胞株: 48G7 / 断片: CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS / プラスミド: PSAL143 / 発現宿主: BL21 / 参照: UniProt: P01857 |
#3: 化合物 | ChemComp-NPE / |
#4: 水 | ChemComp-HOH / |
-実験情報
-実験
実験 | 手法: X線回折 |
---|
-試料調製
結晶 | マシュー密度: 2.45 Å3/Da / 溶媒含有率: 44.8 % | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶 | *PLUS | ||||||||||||||||||||||||||||||
結晶化 | *PLUS pH: 7 / 手法: unknown | ||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
放射光源 | 由来: シンクロトロン / サイト: SSRL / ビームライン: BL7-1 / 波長: 1.08 |
---|---|
検出器 | タイプ: MARRESEARCH / 検出器: IMAGE PLATE / 日付: 1994年6月6日 |
放射 | 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.08 Å / 相対比: 1 |
反射 | 解像度: 1.95→20 Å / Num. obs: 33282 / % possible obs: 96.7 % / Observed criterion σ(I): 0 / 冗長度: 3.8 % / Rmerge(I) obs: 0.072 |
反射 | *PLUS Num. measured all: 121262 |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 1.95→20 Å / σ(F): 0 /
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.95→20 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: X-PLOR / バージョン: 3.1 / 分類: refinement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS Rfactor Rfree: 0.3076 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS |